fbpx
EMAIL US AT info@bcan.org
Contact Us 888-901-2226
Donate Now

Immunotherapy

Questions & Answers about Immunotherapy and Bladder Cancer 

Presented by Dr. Jonathan Rosenberg from Memorial Sloan-Kettering Cancer Center

Year: 2017


Part I: Bladder Cancer & the Immune System

Video  |  Text Transcript


Part II: Clinical Trials in Metastatic Bladder Cancer with Prior Treatment

Video |  Text Transcript


Part III: Clinical Trials in Metastatic Bladder Cancer without Prior Treatment

Video |  Text Transcript


Part IV: Question & Answer Session

Video |  Text Transcript

 

Peter H. O’Donnell, MD, from The University of Chicago, Section of Hematology/Oncology, explains immunotherapy as a bladder cancer treatment and addresses questions about how immune therapies work.
Thank you to our sponsors, EMD Serono & Pfizer and AstraZeneca for their support.

More than 80,000 people will be
diagnosed with bladder cancer in 2019.

We dream of a world without bladder cancer,
the sixth-most frequently diagnosed cancer in the U.S.

Can you help support our vision by making a
tax-deductible contribution today?